However, knockouts of EBI2 and the oxysterol-producing enzymes Ch25h and Cyp7b1 did not show significant differences in NAFLD disease activity, excluding an essential role of these genes, at least in this murine model of NASH. The gene discussed is GPR183; the disease is metabolic dysfunction-associated steatotic liver disease.